JP2009531310A5 - - Google Patents

Download PDF

Info

Publication number
JP2009531310A5
JP2009531310A5 JP2008558555A JP2008558555A JP2009531310A5 JP 2009531310 A5 JP2009531310 A5 JP 2009531310A5 JP 2008558555 A JP2008558555 A JP 2008558555A JP 2008558555 A JP2008558555 A JP 2008558555A JP 2009531310 A5 JP2009531310 A5 JP 2009531310A5
Authority
JP
Japan
Prior art keywords
virus
sophorolipid
glucopyranosyl
lactone
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008558555A
Other languages
English (en)
Japanese (ja)
Other versions
JP5394073B2 (ja
JP2009531310A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/063701 external-priority patent/WO2007130738A1/en
Publication of JP2009531310A publication Critical patent/JP2009531310A/ja
Publication of JP2009531310A5 publication Critical patent/JP2009531310A5/ja
Application granted granted Critical
Publication of JP5394073B2 publication Critical patent/JP5394073B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008558555A 2006-03-09 2007-03-09 様々な形態のソホロ脂質の抗ヘルペスウイルス特性 Expired - Fee Related JP5394073B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78077006P 2006-03-09 2006-03-09
US60/780,770 2006-03-09
PCT/US2007/063701 WO2007130738A1 (en) 2006-03-09 2007-03-09 Anti-herpes virus properties of various forms of sophorolipids

Publications (3)

Publication Number Publication Date
JP2009531310A JP2009531310A (ja) 2009-09-03
JP2009531310A5 true JP2009531310A5 (zh) 2013-08-01
JP5394073B2 JP5394073B2 (ja) 2014-01-22

Family

ID=38668092

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008558555A Expired - Fee Related JP5394073B2 (ja) 2006-03-09 2007-03-09 様々な形態のソホロ脂質の抗ヘルペスウイルス特性

Country Status (3)

Country Link
EP (1) EP1991238A4 (zh)
JP (1) JP5394073B2 (zh)
WO (1) WO2007130738A1 (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2555620A4 (en) * 2010-04-05 2013-10-23 Politechnic Inst Univ New York Sophorolipid ANALOG COMPOSITIONS
EP2532232A1 (en) 2011-06-10 2012-12-12 InterMed Discovery GmbH Long chain glycolipids useful to avoid perishing or microbial contamination of materials
WO2013129667A1 (ja) 2012-03-02 2013-09-06 サラヤ株式会社 高純度酸型ソホロリピッド含有物及びその製造方法
FR2991688B1 (fr) 2012-06-06 2015-05-22 Soliance Biosolubilisant
JP6449156B2 (ja) 2013-08-09 2019-01-09 サラヤ株式会社 新型ソホロリピッド化合物及びそれを含有する組成物
CN105683329B (zh) * 2013-09-04 2018-04-06 莎罗雅株式会社 低毒性的含有槐糖脂的组合物及其用途
JP6275820B2 (ja) 2014-03-10 2018-02-07 サラヤ株式会社 ソホロリピッドと生理活性物質と油脂とを含有する組成物およびその製造方法
US10190038B2 (en) 2014-04-21 2019-01-29 Baker Hughes, A Ge Company, Llc Method of using sophorolipids in well treatment operations
US9884986B2 (en) 2014-04-21 2018-02-06 Baker Hughes, A Ge Company, Llc Method of using biosurfactants as acid corrosion inhibitors in well treatment operations
JP6611221B2 (ja) * 2014-06-12 2019-11-27 花王株式会社 ソフォロリピッドの製造方法
JP6157524B2 (ja) * 2015-03-04 2017-07-05 サラヤ株式会社 低毒性ソホロリピッド含有組成物及びその用途
JP2016160264A (ja) * 2016-01-04 2016-09-05 サラヤ株式会社 低毒性ソホロリピッド含有組成物及びその用途
PL3594318T3 (pl) 2017-03-07 2024-05-20 Saraya Co., Ltd. Kompozycja detergentowa
CN111053734A (zh) * 2020-01-16 2020-04-24 山东大学 一种抗痤疮丙酸杆菌及其生物膜的药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2267678A1 (en) * 1996-10-17 1998-04-23 Alterna Inc. Germicidal composition
US20040242501A1 (en) * 2003-03-20 2004-12-02 Gross Richard A. Spermicidal and virucidal properties of various forms of sophorolipids
US20050164955A1 (en) * 2003-11-06 2005-07-28 Gross Richard A. Antifungal properties of various forms of sophorolipids

Similar Documents

Publication Publication Date Title
JP2009531310A5 (zh)
JP5394073B2 (ja) 様々な形態のソホロ脂質の抗ヘルペスウイルス特性
Aricibasi et al. Differences in genetic background influence the induction of innate and acquired immune responses in chickens depending on the virulence of the infecting infectious bursal disease virus (IBDV) strain
Mohapatra et al. Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma
Folsom et al. Exercise alters the immune response to equine influenza virus and increases susceptibility to infection
CN113304166B (zh) 核苷类化合物在制备治疗冠状病毒感染性疾病的药物中的用途
JP2014505076A (ja) 抗ウイルス剤としてのｍＴＯＲキナーゼの阻害剤
TW202042828A (zh) 抑制病毒感染的方法及組合物
CN103687599A (zh) 氯喹或氯丙嗪或其衍生物或它们的混合物在制备用于治疗和/或预防肺感染和损伤的药物中的用途
KR20140027987A (ko) 인플루엔자 바이러스 복제를 억제하는 방법 및 약학조성물
Pedrazini et al. L‐lysine: its antagonism with L‐arginine in controlling viral infection. Narrative literature review
Scott et al. Defective interfering virus protects elderly mice from influenza
Crowe Jr Host responses to respiratory virus infection and immunization
Ison et al. Current research on respiratory viral infections: Fourth International Symposium
CN107308168A (zh) 一种抑制猪繁殖与呼吸综合征病毒细胞内复制的药物
Yegoraw et al. Transmission of infectious laryngotracheitis virus vaccine and field strains: the role of degree of contact and transmission by whole blood, plasma and poultry dust
US20230270826A1 (en) Antiviral use of liraglutide and gefitinib
JP7293225B2 (ja) 組合せ製品を用いるｒｓｖの処置
RU2563351C2 (ru) ШТАММ ВИРУСА ГРИППА А/17/Ануи/2013/61 (H7N9) ДЛЯ ПРОИЗВОДСТВА ЖИВОЙ ИНТРАНАЗАЛЬНОЙ ГРИППОЗНОЙ ВАКЦИНЫ
Hsu et al. Viral infections in patients with hematological malignancies
EP4132503A1 (en) Methods for treatment of coronavirus infections
Steffenhagen et al. Evaluation of 6-Azauridine and S-Iododeoxyuridine in the Treatment of Experimental Viral Infections
Desheva Introductory chapter: Human adenoviruses
JP2020532588A (ja) シアノバクテリア抽出物、その調製法と利用法
Kloover et al. Persistent rat cytomegalovirus (RCMV) infection of the salivary glands contributes to the anti-RCMV humoral immune response